 |
Download Printable PDF | Back |
The Jordan Company Closes $3.6 Billion Private Equity Fund
• Team has 17-Year History of Investing Together
• Continued Focus on Middle Market and Operational Improvement
New York, NY: January 29, 2008 - The Jordan Company LP, a leading middle market private equity firm with a 30- year history of investing in partnership with management, today announced the final closing of its second private equity fund with commitments totaling $3.6 billion.
Called The Resolute Fund II, L.P., the fund is managed by six managing principals who have been investing together at The Jordan Company for more than 17 years, including John ('Jay') Jordan II, Jonathan ('Jeb') Boucher, A. Richard Caputo, Adam Max, Thomas Quinn and David Zalaznick. They are joined by a team of investment professionals and operating executives in the firm's Operations Management Group. The firm is headquartered in New York and has offices in Chicago, Beijing and Shanghai.
"We are very pleased to have completed a successful fundraising above our original target," said Jordan. "We have amassed a very strong and internationally diverse group of institutional Limited Partners who understand our value-added investment approach, and appreciate the hands-on operational expertise we employ to enhance the growth of our portfolio companies. We are thankful for their continued confidence and support." Fund investors include, CalSTRS, CPP Investment Board, New Jersey Investment Board, Irish National Pensions Reserves Fund, Illinois State Board of Investment, New York State Teachers Retirement System and TIAA-CREF.
Four investments have been completed in The Jordan Company's Resolute Fund II between the first and final closings. The new investments are:- Harrington Holdings, a leading marketer and distributor of healthcare products;
- Production Resource Group, the world's largest independent provider of lighting equipment and services to the premier live event industry, operating as a single-source provider of technology solutions;
- Omnimedia, an integrated TV advertising and other advertising media company located in China, and;
- Worldwide Clinical Trials, a global Contract Research Organization that provides early and late stage drug development services.
The Jordan Company received legal advice from Mayer Brown LLP, and Credit Suisse acted as placement agent in connection with the fundraising.